Immuneering

IMRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$291.785 M

$4.51 +1.12%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$56.0M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#237Fulcrum TherapeuticsFULC$296.8M
#238Bicycle TherapeuticsBCYC$291.9M
#239ImmuneeringIMRX$291.8M
#240Jupiter NeurosciencesJUNS$288.3M
#241Natures Sunshine ProductsNATR$288.0M

Where these numbers come from

Share counts and financials for Immuneering are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.